- 1. Secure our presence in the generics business.
- 2. Achieve a stronger position in the hyperuricemia market, centered on Uralyt.
- 3. Contribute to society through proprietary developments toward drug discovery.
The goal of the Chemiphar Group is to make a difference in society by providing pharmaceutical drugs and health-related services to help people become and remain healthy.
October 31, 2023 | Summary of Consolidated Financial Results for the Second Quarter of Fiscal Year 2023. (pdf, 157KB) |
---|---|
October 31, 2023 | |
October 20, 2023 | Chemiphar Underwrites Third-Party Allocation of Shares by Delta-Fly Pharma. (pdf, 134KB) |
August 25, 2023 | |
July 31, 2023 | Summary of consolidated financial results for the first quarter of FY2023. (pdf, 151KB) |
July 31, 2023 | |
June 07, 2023 | |
May 30, 2023 | Notice of the 91st Ordinary General Meeting of Shareholders. (pdf, 308KB) |
May 22, 2023 | |
May 12, 2023 | Summary of Consolidated Financial Results for the Fiscal Year 2022. (pdf, 169KB) |